THE BLACK HOLE
Contrary to current thinking in Canadian circles, David Kent says it is absolutely essential to tie the program to funding.
While anything can be funded, scientific research teams often need to demonstrate a realistic path to a financial return on investment to get funded.
The current academic career structure rewards short-term deliverables rather than high-risk, high-reward research.
How the Bayh-Dole Act succeeded in kickstarting an explosion of technological innovation.
The culture of scientific research desperately needs a makeover. Enter the eLife Ambassador program.
Translational research should be scientist-driven and institutionally supported, not the other way around.
After nearly 10 years, some issues have definitely moved on, but so many are still stuck in really dark and nasty places.
Feedback from multiple sources ensures that faculty are not disillusioning themselves with misguided opinions on their strengths and weaknesses.
Public perception of which cancers get research funding differs greatly from what actually gets funded. Here’s why.
While every organization is different, sharing best practices can help inform process development.
It is sad that highly-qualified, highly-educated scientific researchers need to worry about pleading their case to have a national pension contribution.
The scientific profession is not for everyone, but there is no reason why we should actively be forcing people out.
How about offering permanent lecturers the ability to undertake research in a leading lab in the same department?
While no one is arguing for funding failure, the challenge is how we define “success.”
David Kent looks at whether it is ethical (and legal) for an academic to share a paper they are reviewing with their lab group.
Among the most interesting implications is the recognition that universities are not exempt from patent infringement for basic research.
I can happily report that something has indeed changed at NSERC and the number of postdoctoral fellowships being awarded is definitely recovering.
This U.S. act allows biotech startups to use patented technology for the purposes of generating data for FDA approval without needing to take out costly licenses.
David Kent looks at some of the new ways scientific journals are trying to fix the current peer review system.
Kevin Leland created Halo, a curated fundraising platform for medical research, so that promising discoveries had a fighting chance to make it across the valley.